Atypical Antipsychotics and Metabolic Outcomes in Chinese Patients A Comparison of Olanzapine and Risperidone

被引:6
作者
Lee, Edwin [1 ]
Leung, Chi-Ming [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Psychiat, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1097/JCP.0b013e31818ce71f
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:707 / 709
页数:3
相关论文
共 8 条
  • [1] Carcinoid tumor of the middle ear: a case report
    Chan, KC
    Wu, CM
    Huang, SF
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2005, 26 (01) : 57 - 59
  • [2] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, R
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Cleeman, JI
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    Keller, SA
    Jehle, AJ
    [J]. CIRCULATION, 2002, 106 (25) : 3143 - 3421
  • [3] Henderson DC, 2005, J CLIN PSYCHIAT, V66, P11
  • [4] An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients
    Koro, CE
    Fedder, DO
    L'Italien, G
    Weiss, S
    Magder, LS
    Kreyenbuhl, J
    Revicki, D
    Buchanan, RW
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (11) : 1021 - 1026
  • [5] Adverse metabolic effects associated with atypical antipsychotics - Literature review and clinical implications
    Melkersson, K
    Dahl, ML
    [J]. DRUGS, 2004, 64 (07) : 701 - 723
  • [6] A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: Metabolic outcomes after 1 year
    Meyer, JM
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (05) : 425 - 433
  • [7] Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline
    Nasrallah, Henry A.
    Meyer, Jonathan M.
    Goff, Donald C.
    McEvoy, Joseph P.
    Davis, Sonia M.
    Stroup, I. Scott
    Lieberman, Jeffrey A.
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 86 (1-3) : 15 - 22
  • [8] Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8